Researchers at King’s College London have identified a new gene (PIM1), which could be an effective target for innovative treatments and therapies for the human autoimmune disease, psoriasis.Read More
The January issue of the British Journal of Dermatology sees the launch of a new initiative: plain language summaries of selected studies. The BJD plain language summaries will open up important...Read More
PAPAA made available today the latest in its range of information leaflets aimed at people with psoriasis. The new leaflet called Psoriasis and phototherapy, explains what phototherapy is, what...Read More
PAPAA is a certified member of the Information Standard Scheme.  The scheme was developed by the Department of Health to help the public identify trustworthy health and social care information easily. At the heart of the scheme is the standard itself – a set of criteria that defines good quality health or social care information and the methods needed to produce it. To achieve the standard, organisations have to show that their processes and systems produce information that is:accurate impartial, balanced, evidence-based, accessible and well-written.